Diabetes
Showing NaN - NaN of 96
Diabetes, Diabetes, Diabetes, Type 1 Trial in Chicago (Diabetes Self-Management Training (DSMT), Remote Glucose Monitoring
Not yet recruiting
- Diabetes
- +3 more
- Diabetes Self-Management Training (DSMT)
- +2 more
-
Chicago, IllinoisMount Sinai Hospital
Sep 13, 2023
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Enrolling by invitation
- Diabetes
- +4 more
-
Phoenix, Arizona
- +26 more
Jan 19, 2023
Surgical Site Infection, Obesity, Diabetes Trial in United States (Negative Pressure Wound Therapy)
Completed
- Surgical Site Infection
- +3 more
- Negative Pressure Wound Therapy
-
Atlanta, Georgia
- +4 more
Nov 17, 2022
Diabetes, Breast Cancer Trial in Chicago, New Hyde Park, New York (Integrated Intervention for Breast Cancer Survivors with
Recruiting
- Diabetes
- Breast Cancer
- Integrated Intervention for Breast Cancer Survivors with Diabetes
- Attention Control
-
Chicago, Illinois
- +2 more
Apr 13, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +3 more
-
Concord, California
- +166 more
Jan 6, 2022
Hypertension, Diabetes Trial in Chicago, Cleveland (Open Access Audio, No Access, Patient and Provider Aware of Recording, No
Recruiting
- Hypertension
- Diabetes
- Open Access Audio
- +2 more
-
Chicago, Illinois
- +1 more
Oct 6, 2021
COPD, Diabetes, Hypertension Trial in Chicago, New York (Supportive counseling, Education on SMB, Psychoeducation on ATs for
Completed
- COPD
- +2 more
- Supportive counseling
- +3 more
-
Chicago, Illinois
- +1 more
Jun 4, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- oral placebo
-
Tucson, Arizona
- +102 more
Jan 14, 2021
Home Sleep and Circadian Phase: Mediators of Diabetes Risk
Completed
- Sleep Deprivation
- +2 more
-
Chicago, IllinoisNorthwestern University
Nov 24, 2020
Diabetes, Diabetes Type 2 Trial in United States (Liraglutide, Metformin, Placebo)
Completed
- Diabetes
- Diabetes Mellitus Type 2
- Liraglutide
- +3 more
-
Chino, California
- +19 more
Jul 20, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +118 more
Feb 14, 2020
Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of
Completed
- Acute Ischemic Stroke
- +2 more
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
-
Tucson, Arizona
- +69 more
Dec 13, 2019
Diabetes, Type 1 Diabetes Trial in Chicago, Boston, Houston (Blood testing)
Completed
- Diabetes
- Type 1 Diabetes
- Blood testing
-
Chicago, Illinois
- +2 more
Dec 14, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +208 more
Oct 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Phoenix, Arizona
- +98 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019